These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 22943868)
1. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy]. Xue K; Qian J; Yue H; Yuan YF; Zhang R Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868 [TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Shields CL; Palamar M; Sharma P; Ramasubramanian A; Leahey A; Meadows AT; Shields JA Arch Ophthalmol; 2009 Mar; 127(3):282-90. PubMed ID: 19273791 [TBL] [Abstract][Full Text] [Related]
3. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy. Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769 [TBL] [Abstract][Full Text] [Related]
4. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977 [TBL] [Abstract][Full Text] [Related]
5. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma]. Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057 [TBL] [Abstract][Full Text] [Related]
6. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL; Shelil A; Cater J; Meadows AT; Shields JA Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913 [TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [TBL] [Abstract][Full Text] [Related]
8. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743 [TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213 [TBL] [Abstract][Full Text] [Related]
10. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Abramson DH; Schefler AC Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378 [TBL] [Abstract][Full Text] [Related]
11. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319 [TBL] [Abstract][Full Text] [Related]
12. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863 [TBL] [Abstract][Full Text] [Related]
13. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP; Honavar SG; Reddy VA; Khanna R Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675 [TBL] [Abstract][Full Text] [Related]
15. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Demirci H; Eagle RC; Shields CL; Shields JA Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690 [TBL] [Abstract][Full Text] [Related]
16. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study. Chawla B; Jain A; Seth R; Azad R; Mohan VK; Pushker N; Ghose S Indian J Ophthalmol; 2016 Jul; 64(7):524-9. PubMed ID: 27609166 [TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment]. Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843 [TBL] [Abstract][Full Text] [Related]
19. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma. Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962 [TBL] [Abstract][Full Text] [Related]